 Ginkgo Bioworks Holdings Inc NYSE: DNA reported Q4 FY21 sales of 148.5 million, up 363 YY, beating the consensus of 94.81 million. The current market environment provides challenges and opportunities, but Ive never been more excited about Ginkgos future, said. 